Embracing mRNA Potential
Stéphane shares his disciplined approach to scaling a company, emphasizing strategic priorities and impactful acquisitions. When approached by Noubar to lead a small biotech firm focused on mRNA technology, he recognized the groundbreaking potential, despite the daunting odds of success. This episode delves into the revolutionary nature of mRNA vaccines and the bold decisions that shaped the future of healthcare.In this clip
From this podcast
Masters of Scale
Extraordinary leaps need solid foundations, part 1, w/Moderna CEO Stéphane Bancel
Related Questions